Status:
UNKNOWN
Effect of the Enteric Hormone Glucagon-Like Peptide (GLP-2) on the Intestinal Blood Flow in Patients With Short Bowel Syndrome
Lead Sponsor:
Glostrup University Hospital, Copenhagen
Conditions:
Short Bowel Syndrome
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
The aim of the study is to investigate the effect of the enteric hormone Glucagon-like Peptide (GLP-2) on patients with short bowel syndrome
Detailed Description
previous studies have shown that GLP-2 increases mesenteric blow flow, we wish to examine the effect of subcutaneus GLP-2 on patients with short bowl syndrome. The patients will single blinded been gi...
Eligibility Criteria
Inclusion
- clinical diagnose of short bowel syndrome 4 month of stable fase
Exclusion
- activity in IBD
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT00673751
Last Update
May 7 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Glostrup University Hospital
Glostrup Municipality, Capital Region, Denmark, 2600